Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis

Mod Rheumatol. 2007;17(6):531-3. doi: 10.1007/s10165-007-0632-5. Epub 2007 Dec 20.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibody Formation / immunology*
  • Antirheumatic Agents / immunology*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / immunology*
  • Etanercept
  • Humans
  • Immunocompetence / drug effects
  • Immunocompetence / immunology*
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Influenza Vaccines / immunology*
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Influenza Vaccines
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept